Therapeutic Nuclear Medicines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Therapeutic Nuclear Medicines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Therapeutic Nuclear Medicines industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Therapeutic Nuclear Medicines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Therapeutic Nuclear Medicines worldwide and market share by regions, with company and product introduction, position in the Therapeutic Nuclear Medicines market
Market status and development trend of Therapeutic Nuclear Medicines by types and applications
Cost and profit status of Therapeutic Nuclear Medicines, and marketing status
Market growth drivers and challenges
The report segments the global Therapeutic Nuclear Medicines market as:
Global Therapeutic Nuclear Medicines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Therapeutic Nuclear Medicines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
Global Therapeutic Nuclear Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Other
Global Therapeutic Nuclear Medicines Market: Manufacturers Segment Analysis (Company and Product introduction, Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin):
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Therapeutic Nuclear Medicines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Therapeutic Nuclear Medicines industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Therapeutic Nuclear Medicines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Therapeutic Nuclear Medicines worldwide and market share by regions, with company and product introduction, position in the Therapeutic Nuclear Medicines market
Market status and development trend of Therapeutic Nuclear Medicines by types and applications
Cost and profit status of Therapeutic Nuclear Medicines, and marketing status
Market growth drivers and challenges
The report segments the global Therapeutic Nuclear Medicines market as:
Global Therapeutic Nuclear Medicines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Therapeutic Nuclear Medicines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
Global Therapeutic Nuclear Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Other
Global Therapeutic Nuclear Medicines Market: Manufacturers Segment Analysis (Company and Product introduction, Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin):
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF THERAPEUTIC NUCLEAR MEDICINES
1.1 Definition of Therapeutic Nuclear Medicines in This Report
1.2 Commercial Types of Therapeutic Nuclear Medicines
1.2.1 Beta Emitters Therapeutic Nuclear Medicines
1.2.2 Alpha Emitters Therapeutic Nuclear Medicines
1.2.3 Brachytherapy Therapeutic Nuclear Medicines
1.3 Downstream Application of Therapeutic Nuclear Medicines
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Other
1.4 Development History of Therapeutic Nuclear Medicines
1.5 Market Status and Trend of Therapeutic Nuclear Medicines 2013-2023
1.5.1 Global Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
1.5.2 Regional Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Therapeutic Nuclear Medicines 2013-2017
2.2 Sales Market of Therapeutic Nuclear Medicines by Regions
2.2.1 Sales Volume of Therapeutic Nuclear Medicines by Regions
2.2.2 Sales Value of Therapeutic Nuclear Medicines by Regions
2.3 Production Market of Therapeutic Nuclear Medicines by Regions
2.4 Global Market Forecast of Therapeutic Nuclear Medicines 2018-2023
2.4.1 Global Market Forecast of Therapeutic Nuclear Medicines 2018-2023
2.4.2 Market Forecast of Therapeutic Nuclear Medicines by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Therapeutic Nuclear Medicines by Types
3.2 Sales Value of Therapeutic Nuclear Medicines by Types
3.3 Market Forecast of Therapeutic Nuclear Medicines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Therapeutic Nuclear Medicines by Downstream Industry
4.2 Global Market Forecast of Therapeutic Nuclear Medicines by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Therapeutic Nuclear Medicines Market Status by Countries
5.1.1 North America Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
5.1.2 North America Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
5.1.3 United States Therapeutic Nuclear Medicines Market Status (2013-2017)
5.1.4 Canada Therapeutic Nuclear Medicines Market Status (2013-2017)
5.1.5 Mexico Therapeutic Nuclear Medicines Market Status (2013-2017)
5.2 North America Therapeutic Nuclear Medicines Market Status by Manufacturers
5.3 North America Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
5.3.1 North America Therapeutic Nuclear Medicines Sales by Type (2013-2017)
5.3.2 North America Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
5.4 North America Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Therapeutic Nuclear Medicines Market Status by Countries
6.1.1 Europe Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
6.1.2 Europe Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
6.1.3 Germany Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.4 UK Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.5 France Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.6 Italy Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.7 Russia Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.8 Spain Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.9 Benelux Therapeutic Nuclear Medicines Market Status (2013-2017)
6.2 Europe Therapeutic Nuclear Medicines Market Status by Manufacturers
6.3 Europe Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
6.3.1 Europe Therapeutic Nuclear Medicines Sales by Type (2013-2017)
6.3.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
6.4 Europe Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Therapeutic Nuclear Medicines Market Status by Countries
7.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
7.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
7.1.3 China Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.4 Japan Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.5 India Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.6 Southeast Asia Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.7 Australia Therapeutic Nuclear Medicines Market Status (2013-2017)
7.2 Asia Pacific Therapeutic Nuclear Medicines Market Status by Manufacturers
7.3 Asia Pacific Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
7.3.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2013-2017)
7.3.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
7.4 Asia Pacific Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Therapeutic Nuclear Medicines Market Status by Countries
8.1.1 Latin America Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
8.1.2 Latin America Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
8.1.3 Brazil Therapeutic Nuclear Medicines Market Status (2013-2017)
8.1.4 Argentina Therapeutic Nuclear Medicines Market Status (2013-2017)
8.1.5 Colombia Therapeutic Nuclear Medicines Market Status (2013-2017)
8.2 Latin America Therapeutic Nuclear Medicines Market Status by Manufacturers
8.3 Latin America Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
8.3.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2013-2017)
8.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
8.4 Latin America Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Countries
9.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
9.1.3 Middle East Therapeutic Nuclear Medicines Market Status (2013-2017)
9.1.4 Africa Therapeutic Nuclear Medicines Market Status (2013-2017)
9.2 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Manufacturers
9.3 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2013-2017)
9.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
9.4 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
10.1 Global Economy Situation and Trend Overview
10.2 Therapeutic Nuclear Medicines Downstream Industry Situation and Trend Overview
CHAPTER 11 THERAPEUTIC NUCLEAR MEDICINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Therapeutic Nuclear Medicines by Major Manufacturers
11.2 Production Value of Therapeutic Nuclear Medicines by Major Manufacturers
11.3 Basic Information of Therapeutic Nuclear Medicines by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Therapeutic Nuclear Medicines Major Manufacturer
11.3.2 Employees and Revenue Level of Therapeutic Nuclear Medicines Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 THERAPEUTIC NUCLEAR MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Cardinal Health
12.1.1 Company profile
12.1.2 Representative Therapeutic Nuclear Medicines Product
12.1.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Cardinal Health
12.2 Mallkrodt Plc
12.2.1 Company profile
12.2.2 Representative Therapeutic Nuclear Medicines Product
12.2.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Mallkrodt Plc
12.3 GE Healthcare
12.3.1 Company profile
12.3.2 Representative Therapeutic Nuclear Medicines Product
12.3.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of GE Healthcare
12.4 Lantheus Medical Imaging
12.4.1 Company profile
12.4.2 Representative Therapeutic Nuclear Medicines Product
12.4.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging
12.5 Bayer AG
12.5.1 Company profile
12.5.2 Representative Therapeutic Nuclear Medicines Product
12.5.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bayer AG
12.6 Bracco Imaging SpA
12.6.1 Company profile
12.6.2 Representative Therapeutic Nuclear Medicines Product
12.6.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bracco Imaging SpA
12.7 Eczacibasi-Monrol Nuclear Products
12.7.1 Company profile
12.7.2 Representative Therapeutic Nuclear Medicines Product
12.7.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Eczacibasi-Monrol Nuclear Products
12.8 Nordion
12.8.1 Company profile
12.8.2 Representative Therapeutic Nuclear Medicines Product
12.8.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Nordion
12.9 Advanced Accelerator Applications SA
12.9.1 Company profile
12.9.2 Representative Therapeutic Nuclear Medicines Product
12.9.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Advanced Accelerator Applications SA
12.10 IBA Molecular Imaging
12.10.1 Company profile
12.10.2 Representative Therapeutic Nuclear Medicines Product
12.10.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of IBA Molecular Imaging
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
13.1 Industry Chain of Therapeutic Nuclear Medicines
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
14.1 Cost Structure Analysis of Therapeutic Nuclear Medicines
14.2 Raw Materials Cost Analysis of Therapeutic Nuclear Medicines
14.3 Labor Cost Analysis of Therapeutic Nuclear Medicines
14.4 Manufacturing Expenses Analysis of Therapeutic Nuclear Medicines
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Therapeutic Nuclear Medicines in This Report
1.2 Commercial Types of Therapeutic Nuclear Medicines
1.2.1 Beta Emitters Therapeutic Nuclear Medicines
1.2.2 Alpha Emitters Therapeutic Nuclear Medicines
1.2.3 Brachytherapy Therapeutic Nuclear Medicines
1.3 Downstream Application of Therapeutic Nuclear Medicines
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Other
1.4 Development History of Therapeutic Nuclear Medicines
1.5 Market Status and Trend of Therapeutic Nuclear Medicines 2013-2023
1.5.1 Global Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
1.5.2 Regional Therapeutic Nuclear Medicines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Therapeutic Nuclear Medicines 2013-2017
2.2 Sales Market of Therapeutic Nuclear Medicines by Regions
2.2.1 Sales Volume of Therapeutic Nuclear Medicines by Regions
2.2.2 Sales Value of Therapeutic Nuclear Medicines by Regions
2.3 Production Market of Therapeutic Nuclear Medicines by Regions
2.4 Global Market Forecast of Therapeutic Nuclear Medicines 2018-2023
2.4.1 Global Market Forecast of Therapeutic Nuclear Medicines 2018-2023
2.4.2 Market Forecast of Therapeutic Nuclear Medicines by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Therapeutic Nuclear Medicines by Types
3.2 Sales Value of Therapeutic Nuclear Medicines by Types
3.3 Market Forecast of Therapeutic Nuclear Medicines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Therapeutic Nuclear Medicines by Downstream Industry
4.2 Global Market Forecast of Therapeutic Nuclear Medicines by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Therapeutic Nuclear Medicines Market Status by Countries
5.1.1 North America Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
5.1.2 North America Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
5.1.3 United States Therapeutic Nuclear Medicines Market Status (2013-2017)
5.1.4 Canada Therapeutic Nuclear Medicines Market Status (2013-2017)
5.1.5 Mexico Therapeutic Nuclear Medicines Market Status (2013-2017)
5.2 North America Therapeutic Nuclear Medicines Market Status by Manufacturers
5.3 North America Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
5.3.1 North America Therapeutic Nuclear Medicines Sales by Type (2013-2017)
5.3.2 North America Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
5.4 North America Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Therapeutic Nuclear Medicines Market Status by Countries
6.1.1 Europe Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
6.1.2 Europe Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
6.1.3 Germany Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.4 UK Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.5 France Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.6 Italy Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.7 Russia Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.8 Spain Therapeutic Nuclear Medicines Market Status (2013-2017)
6.1.9 Benelux Therapeutic Nuclear Medicines Market Status (2013-2017)
6.2 Europe Therapeutic Nuclear Medicines Market Status by Manufacturers
6.3 Europe Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
6.3.1 Europe Therapeutic Nuclear Medicines Sales by Type (2013-2017)
6.3.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
6.4 Europe Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Therapeutic Nuclear Medicines Market Status by Countries
7.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
7.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
7.1.3 China Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.4 Japan Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.5 India Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.6 Southeast Asia Therapeutic Nuclear Medicines Market Status (2013-2017)
7.1.7 Australia Therapeutic Nuclear Medicines Market Status (2013-2017)
7.2 Asia Pacific Therapeutic Nuclear Medicines Market Status by Manufacturers
7.3 Asia Pacific Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
7.3.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2013-2017)
7.3.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
7.4 Asia Pacific Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Therapeutic Nuclear Medicines Market Status by Countries
8.1.1 Latin America Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
8.1.2 Latin America Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
8.1.3 Brazil Therapeutic Nuclear Medicines Market Status (2013-2017)
8.1.4 Argentina Therapeutic Nuclear Medicines Market Status (2013-2017)
8.1.5 Colombia Therapeutic Nuclear Medicines Market Status (2013-2017)
8.2 Latin America Therapeutic Nuclear Medicines Market Status by Manufacturers
8.3 Latin America Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
8.3.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2013-2017)
8.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
8.4 Latin America Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Countries
9.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries (2013-2017)
9.1.3 Middle East Therapeutic Nuclear Medicines Market Status (2013-2017)
9.1.4 Africa Therapeutic Nuclear Medicines Market Status (2013-2017)
9.2 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Manufacturers
9.3 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2013-2017)
9.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2013-2017)
9.4 Middle East and Africa Therapeutic Nuclear Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
10.1 Global Economy Situation and Trend Overview
10.2 Therapeutic Nuclear Medicines Downstream Industry Situation and Trend Overview
CHAPTER 11 THERAPEUTIC NUCLEAR MEDICINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Therapeutic Nuclear Medicines by Major Manufacturers
11.2 Production Value of Therapeutic Nuclear Medicines by Major Manufacturers
11.3 Basic Information of Therapeutic Nuclear Medicines by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Therapeutic Nuclear Medicines Major Manufacturer
11.3.2 Employees and Revenue Level of Therapeutic Nuclear Medicines Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 THERAPEUTIC NUCLEAR MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Cardinal Health
12.1.1 Company profile
12.1.2 Representative Therapeutic Nuclear Medicines Product
12.1.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Cardinal Health
12.2 Mallkrodt Plc
12.2.1 Company profile
12.2.2 Representative Therapeutic Nuclear Medicines Product
12.2.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Mallkrodt Plc
12.3 GE Healthcare
12.3.1 Company profile
12.3.2 Representative Therapeutic Nuclear Medicines Product
12.3.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of GE Healthcare
12.4 Lantheus Medical Imaging
12.4.1 Company profile
12.4.2 Representative Therapeutic Nuclear Medicines Product
12.4.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging
12.5 Bayer AG
12.5.1 Company profile
12.5.2 Representative Therapeutic Nuclear Medicines Product
12.5.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bayer AG
12.6 Bracco Imaging SpA
12.6.1 Company profile
12.6.2 Representative Therapeutic Nuclear Medicines Product
12.6.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Bracco Imaging SpA
12.7 Eczacibasi-Monrol Nuclear Products
12.7.1 Company profile
12.7.2 Representative Therapeutic Nuclear Medicines Product
12.7.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Eczacibasi-Monrol Nuclear Products
12.8 Nordion
12.8.1 Company profile
12.8.2 Representative Therapeutic Nuclear Medicines Product
12.8.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Nordion
12.9 Advanced Accelerator Applications SA
12.9.1 Company profile
12.9.2 Representative Therapeutic Nuclear Medicines Product
12.9.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of Advanced Accelerator Applications SA
12.10 IBA Molecular Imaging
12.10.1 Company profile
12.10.2 Representative Therapeutic Nuclear Medicines Product
12.10.3 Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin of IBA Molecular Imaging
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
13.1 Industry Chain of Therapeutic Nuclear Medicines
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF THERAPEUTIC NUCLEAR MEDICINES
14.1 Cost Structure Analysis of Therapeutic Nuclear Medicines
14.2 Raw Materials Cost Analysis of Therapeutic Nuclear Medicines
14.3 Labor Cost Analysis of Therapeutic Nuclear Medicines
14.4 Manufacturing Expenses Analysis of Therapeutic Nuclear Medicines
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
